Bedrosian Camille L — SEC Form 4 filings
SEC reporting owner CIK 1326969. 19 Form 4 filings on record with FilingPulse; latest filed 2026-09-14.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2024-04-18 to 2026-09-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 7 filings — 64,396 shares, $798,659 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 30.
- Largest priced transaction: sale of 7,947 shares @ $32.21 ($256,004) in Amylyx Pharmaceuticals, Inc., filed 2026-09-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Medical Officer | 11 | — | 8 legs · 64,396 sh · $798,659 | 7 |
| Crinetics Pharmaceuticals, Inc. (CRNX) | Director | 4 | — | — | 15 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | Director | 4 | — | — | 8 |
Form 4 filings — Bedrosian Camille L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-14 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 7,947 @ $32.21 · Sale (S): 2,081 @ $33.09 | EDGAR |
| 2026-09-01 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Disposition to issuer (D): 16,300 @ $85 · Disposition to issuer (D): 5,925 @ $85 · Disposition to issuer (D): 25,000 (derivative) @ $68.92 · Disposition to issuer (D): 17,500 (derivative) @ $64.77 · Disposition to issuer (D): 17,500 (derivative) @ $66.71 · Disposition to issuer (D): 17,500 (derivative) @ $64.68 · +3 more | EDGAR |
| 2026-08-20 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 22,807 @ $0 | EDGAR |
| 2026-06-22 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 5,925 @ $0 · Grant/award (A): 9,730 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 95,990 @ $0 · Grant/award (A): 143,985 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 6,461 @ $14.58 | EDGAR |
| 2025-12-03 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 6,580 @ $14.35 | EDGAR |
| 2025-10-02 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 12,039 @ $14.58 | EDGAR |
| 2025-06-26 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 7,037 (derivative) @ $0 · Grant/award (A): 4,712 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 4,000 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 6,900 @ $0 · Grant/award (A): 10,350 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 12,425 @ $3.47 | EDGAR |
| 2025-03-10 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 68,420 @ $0 · Grant/award (A): 102,630 (derivative) @ $0 | EDGAR |
| 2024-12-03 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 5,421 @ $5.54 | EDGAR |
| 2024-10-02 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 11,442 @ $3.20 | EDGAR |
| 2024-06-25 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 3,000 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 14,000 (derivative) @ $0 · Grant/award (A): 4,000 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 3,400 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-04-18 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 96,910 @ $0 · Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1326969 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →